Target intelligence / Profile preview

Microtubule cross-linking factor 2 (MTCL2)

Target
MTCL2
Molecular classification
Other (Microtubule-associated protein)
01

Overview

Microtubule cross-linking factor 2 (MTCL2) is a cytoskeletal protein that organizes perinuclear microtubules by crosslinking them on the Golgi membrane, supporting directional cell migration and proper Golgi ribbon morphology. MTCL2 binds microtubules via its C-terminal domain and associates with Golgi membranes through its N-terminal coiled-coil region. It is essential for faithful chromosome segregation during mitosis and, through its autophagy-regulating functions, plays a role in reducing cellular glucose production in an insulin-dependent manner. MTCL2 is not a conventional drug target enzyme, receptor, channel, or transporter, and there are currently no drugs known to specifically modulate its activity.

Other names
Microtubule cross-linking factor 2, N-terminal formC-terminal 80 kDa formMTCL2C20orf117KIAA0889SOGASOGA180-kDa SOGA fragmentdJ132F21.1FLJ44670SOGA family member 1Suppressor of glucose by autophagySuppressor of glucose, autophagy-associated protein 1Suppressor of glucose from autophagyProtein SOGA1
02

Biological functions

Microtubule crosslinking and organizationChromosome segregation during mitosisRegulation of autophagyNegative regulation of gluconeogenesisInsulin signaling pathway participationDirectional cell migration and polarity
03

Disease associations

Dystonia 26, myoclonicEnterokinase deficiencyOther (no strong evidence for major common disease associations; primarily studied for basic biology)

Beyond the preview

Go deeper on Microtubule cross-linking factor 2 (MTCL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule cross-linking factor 2 (MTCL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call